Annual Report - Moffitt Cancer Center

ANNUAL REPORT 2015
A SHARED WAY OF LIFE
Embracing Research, Treatment and Prevention
Moffitt Cancer Center was established in 1981
LEADERSHIP MESSAGE
by the Florida Legislature to address the state’s
Robert Rothman
Chairman
cancer burden. The center was named after
H. Lee Moffitt, former Speaker of the Florida
House of Representatives. In 1977, Moffitt lost
three friends to cancer — each of whom had to
seek sophisticated cancer treatment outside
of Florida. Out of Moffitt’s sadness was born a
resolve that would direct his efforts for years
to come. In 1982, as the incoming speaker of
the Florida House of Representatives, Moffitt
worked tirelessly to influence legislation that
established a cancer center in Tampa.
Alan F. List, M.D.
President and Chief
Executive Officer
Dear Friends,
We are pleased to share Moffitt Cancer Center’s 2015 Annual Report, which exhibits our continued
achievements in scientific innovation, new treatments, campus expansion and more.
TABLE OF CONTENTS
Message From President & CEO
3
Overview of Prevention Initiatives
4
Patient Care
7
Community Benefit
8
2015 Highlights
10
Accolades & Recognitions
12
New Appointments
13
Leadership Listing
14
Moffitt’s mission is to contribute
to the prevention and cure of cancer.
We are especially proud to announce that Moffitt received the prestigious Magnet designation in recognition
of its nursing excellence in 2015. This designation recognizes nursing professionalism, teamwork, quality
patient care and innovations in nursing practices.
The importance of bringing the benefits of scientific discoveries closer to the patient is clearly seen in
Moffitt’s translational research and clinical trials. Moffitt recently treated the first patient nationally in a
clinical trial of KTE-C19, an investigational therapy for aggressive non-Hodgkin lymphoma. And in December
2014, the U.S. Food and Drug Administration approved Gardasil 9, a vaccine that protects against nine
human papillomavirus (HPV) types, following a pivotal international phase II/III clinical trial involving Moffitt
faculty.
From the cancer center’s early years, prevention has played a key role in our mission, and we have included
an overview of Moffitt’s efforts to prevent cancer, including a timeline of key prevention-related initiatives.
The Moffitt McKinley Outpatient Center opened as this annual report went to press. The McKinley Center
fulfills a critical need to meet the increasing demand for expanded outpatient services, as well as an
outpatient surgery center, a cutaneous clinic, a breast clinic, breast imaging services, genetic counseling
and more.
As we approach the cancer center’s 30th anniversary in 2016, we extend our deepest thanks to all of you
who are joining us in the fight against cancer and making these successes possible.
MOFFITT PATIENTS, VOLUNTEERS, RESEARCHERS, PHYSICIANS AND TEAM MEMBERS
share a commitment to prevent cancer through scientific research and new treatments. At Moffitt this is a way of life.
ON THE COVER: LEFT: Darlene Westbrock benefitted from laser surgery performed by Moffitt neurosurgeon Arnold Etame, M.D.
Alan F. List, M.D.
Robert Rothman
President and Chief Executive Officer
Chairman
RIGHT, clockwise from top: Eric Haura, M.D., Howard McLeod, Pharm.D., patient advisor Paul Lombardi, Anna Giuliano, Ph.D., and
Dr. Etame
THIS PAGE: Joel Stettler, R.N., is part of the team of Moffitt nurses instrumental in helping the cancer center earn the prestigious
Magnet designation in recognition of its nursing excellence.
3
To Contribute To
The Prevention And Cure Of Cancer
A HISTORY OF MOFFITT’S EFFORTS TO PREVENT CANCER
After nine years of planning and advocating for funding,
Moffitt Cancer Center opened its doors and began treating
patients in 1986. Today, ask Moffitt team members about
the cancer center’s mission and most will quickly reply:
“To contribute to the prevention and cure of cancer.”
THE EARLY PROGRAMS
Paul B. Jacobsen, Ph.D., came to Moffitt as program leader
for Psychosocial Oncology in 1994, just before the opening
of the Moffitt Research Center in 1995.
Originally built as the USF Eye Institute, the building later
called Moffitt Research Center was given to the cancer
center by the legislature to be used for its burgeoning
research effort. The opening of the research center helped
set the stage for achieving National Cancer Institute (NCI)
Comprehensive Status in 2001.
“From those early years, when Moffitt’s scientific programs
were first established, up until now, prevention has played
a prominent role in our mission,” Dr. Jacobsen says. “As the
cancer center’s research programs continued to develop
and expand, the importance of cancer prevention was
never underestimated.”
By 1996, Moffitt had four active research programs:
Molecular Oncology, Immunology, Experimental
Therapeutics and Cancer Control. The Cancer Control
Program had the prevention of cancer at its heart. By
the turn of the millennium, cancer prevention efforts
continued and even picked up speed, thanks in large part
to the discovery of molecular and genetic markers of
cancer susceptibility, screening interventions that could
lead to prevention, community education and outreach,
and efforts at tobacco control.
POPULATION SCIENCE APPLIES
INTERDISCIPLINARY RESEARCH
By 2002, the goals of the Cancer Control Program also
focused on conducting interdisciplinary research to identify
biological and genetic markers that could both predict
increased cancer susceptibility and evaluate promising
interventions directed at cancer prevention. By 2006, that
program officially split into two programs under the Division
of Cancer Control & Prevention. One is a multi-focused
program called Health Outcomes and Behavior, originally
led by Dr. Jacobsen, with one of its goals being to gain a
better understanding of and promote the behaviors that
Established at Moffitt Cancer Center
Mole Patrol was
established to detect
skin cancers within
the community and to
reduce skin cancer risk.
®
Moffitt Cancer
Center’s early mission
statement included
cancer prevention as
key goal.
Moffitt achieved
designation as a National
Cancer Institute (NCI)
Cancer Center. The Florida
Legislature funded $100
million to expand research
and clinical areas.
1984 1986 1993 1994 1995 1996 1997 1998
Moffitt opened its doors.
Moffitt Cancer Center Screening and
Prevention (originally called Lifetime Cancer
Screening & Diagnostic Center) opened,
along with Cancer Answers, a national tollfree cancer information telephone service.
4
Moffitt Research Center
building opened; initial
program in Cancer Control
was established.
can lead to cancer prevention. The other program evolving
from Cancer Control was Risk Assessment, Detection and
Intervention (RADI), initially led by Anna Giuliano, Ph.D. In
2011, RADI was renamed Cancer Epidemiology. The goal
of the Cancer Epidemiology Program, now led by Peter
Kanetsky, Ph.D., is to contribute to a reduction in the cancer
burden through better knowledge of the etiology of the
disease and translation of that knowledge into effective
early detection and prevention interventions.
Currently, both Health Outcomes and Behavior and
Cancer Epidemiology fall under the Division of Population
Science, led by Dr. Jacobsen. “The Division of Population
Science conducts research along the continuum of cancer
prevention, with a focus on exposures such as genetic
susceptibility, infections and lifestyle factors,” Dr. Jacobsen
says. “The active portfolio of research studies includes
clinical trials to determine the efficacy of vaccines for
preventing cancer and novel approaches for preventing
smoking relapse, as well as community-based studies
to promote cancer screening especially in medically
underserved populations.”
Paul B. Jacobsen, Ph.D.
TIMELINE OF KEY PREVENTION-RELATED INITIATIVES
Dr. Paul Jacobsen was recruited to establish
research and clinical programs in psychosocial
oncology. The Health Outcomes and Behavior
and Cancer Epidemiology Programs fall under
his responsibility in his current role as associate
center director, Division of Population Science.
“From those early years, when Moffitt’s
scientific programs were first established,
up until now, prevention has played a
prominent role in our mission.”
Dr. Thomas Brandon was recruited to
establish research efforts in smoking
cessation. In 2000, he developed a smoking
relapse intervention in the form of a series
of booklets (Forever Free™), which are
disseminated around the world.
Moffitt Program for Outreach
Wellness Education and Resources
(M-POWER; originally called
Community Education and
Outreach) began.
Moffitt achieved NCI
Comprehensive Cancer
Center status.
Moffitt Diversity (formerly
Office of Institutional Diversity)
initiative was established,
serving as a resource to
promote prevention education
among diverse communities.
Cancer Control evolved into
two research programs: Health
Outcomes and Behavior and
Risk Assessment, Detection
and Intervention.
Moffitt Cancer Center
will celebrate its
30th anniversary.
1999 2001 2003 2004 2006 2011 2012 2016
Dr. Thomas Sellers joined Moffitt as associate
center director, Cancer Prevention and
Control; he currently serves as center
director, Moffitt Cancer Center. His arrival
further propelled the cancer center’s cancer
prevention initiatives, and his leadership
continues to foster an environment of team
science aimed at promoting the prevention,
early detection and control of cancer.
Dr. Anna Giuliano was recruited
to establish cancer prevention
vaccine research; in the subsequent
years, she contributed to pivotal
trials that led to the approval of
HPV vaccines and expansion of
indications for vaccination.
Center for Infection Research
in Cancer was established.
Risk Assessment,
Detection and
Intervention was
renamed Cancer
Epidemiology.
5
PATIENT CARE HIGHLIGHTS
Why Focus On Prevention?
According to the National Cancer Institute (NCI), about 1.6
million people were diagnosed with cancer in the United
States in 2014. In addition to the physical and emotional
distress caused by cancer, the high costs of care are a
burden to patients, their families and the public.
Fortunately, the number of new cancer cases can be
lowered and many cancer-related deaths can be avoided
by cancer prevention research and education. Here at
Moffitt our researchers and physicians are studying many
different ways to prevent cancer.
For example, Moffitt faculty have been active in human
papillomavirus (HPV) vaccine research leading to approval
of the Gardasil 9 vaccine. This vaccine has the potential
to increase overall cervical cancer prevention from 70 to
90 percent, nearly eliminating this cancer.
Scientists believe cigarette smoking causes about 30%
of all cancer deaths in the United States. To help combat
these grim statistics, Moffitt has actively promoted tobacco
prevention efforts, including the development of a series of
booklets distributed free of charge by the NCI and offered
at www.smokefree.gov.
AS THE THIRD LARGEST CANCER CENTER IN THE NATION BASED
on outpatient volume, Moffitt offers a level of service that stands above
the rest. Each year, thousands of patients walk through our doors seeking
personalized, compassionate care and hope. We are 100 percent focused
on cancer care, and for our patients, this means better outcomes and the
best chance for beating cancer.
“We know that certain behaviors
increase cancer risk — smoking, lack of
physical activity, too much alcohol and
unsafe sun exposure. The challenge has
been to develop incentives and programs
designed to help people to avoid those
risks and adopt healthier lifestyles.”
CANCER PREVENTION:
A PUBLIC HEALTH APPROACH
1%
PATIENT CARE VOLUMES 2015
206
Beds
18,165
New Patients
346,471
Outpatient Visits
16,117
Screening Visits
9,319
Admissions
No stranger to the importance of prevention, Dr. Sellers
joined Moffitt in 2003 as associate center director
for Cancer Prevention and Control. He has conducted
numerous studies aimed at gaining a better understanding
of the genetic factors associated with cancer risk and using
the findings to better treat cancer and to help prevent it.
9,263
Surgical Cases
6.2 Average Stay (in days)
Important ongoing cancer prevention research and
educational efforts at Moffitt center on tobacco control,
vaccines, genetic screening to determine cancer risk,
colorectal cancer screening and sun safety.
A full-length feature of these and other Moffitt cancer
prevention and screening initiatives can be viewed by
visiting MOFFITT.org/Momentum and selecting Volume
2; Issue 2.
6
Medicaid
Managed Care
Medicaid
10%
Medicare
Managed Care
43%
HMO/PPO
35%
Medicare
2015 PAYER MIX
2%
Hernando
3%
Non-Florida
4% Manatee
4% Sarasota
2.8%
Colon
3.1% Myeloma
3.2% Other hematopoietic
3.4% Bladder
3.7%
32%
Hillsborough
6%
Polk
10%
29.2%
Other Sites
27%
12%
Pinellas
Other FL
Kidney
and renal pelvis
3.9%
Pancreas
4.9%
Pasco
Non-Hodgkin
lymphona
12.4%
Breast
10.2%
Bronchus
11.2% and Lung
Skin**
MOFFITT PATIENT ORIGIN 2015
Thomas A. Sellers, Ph.D., M.P.H.
3%
4%
The public health approach to prevent cancer works at
the population level to reduce or eliminate risk factors
for cancer, notes Center Director Thomas A. Sellers, Ph.D.,
M.P.H. “We know that certain behaviors increase cancer risk
— smoking, lack of physical activity, too much alcohol and
unsafe sun exposure. The challenge has been to develop
incentives and programs designed to help people to avoid
those risks and adopt healthier lifestyles,” Dr. Sellers says.
Under the leadership of Dr. Sellers, two of the cancer center’s
research programs — Health Outcomes and Behavior and
Cancer Epidemiology — were rated “exceptional” during
the 2012 review for the National Cancer Institute Cancer
Center Support Grant renewal. This is the highest possible
rank from the NCI’s extensive peer-review process for
cancer center grant funding.
1% Private Pay
3% Other
Commerical
6.0%
Leukemia
6.0%
Prostate
10 MOST FREQUENT CANCER SITES 2014*
*Includes analytic and non-analytic cases for accession year 2014.
**Excludes basal cell and squamous cell carcinoma.
There were a total of 9,725 analytic and non-analytic cases for
accession year 2014. Source: Cancer Registry
7
COMMUNITY BENEFIT
COMMUNITY BENEFIT
HIGHLIGHTS OF COMMUNITY BENEFIT INITIATIVES
Moffitt Cancer Center’s Community Benefit initiatives provide patient-centered and
culturally competent outreach, education, training and resources throughout the greater
Tampa Bay community and the state of Florida to support patients, families and clinicians
in advancing cancer prevention, early detection, clinical care and research, especially
for those at-risk populations disproportionately impacted by the disease. Moffitt’s 2012
Community Health Needs Assessment identified five priority health needs. Below are
examples of how Moffitt is addressing two priority health needs in order to improve
the health of the community and the people it served from July 2014 – June 2015.
n TRADITIONAL CHARITY CARE
Total cost of services incurred by Moffitt to provide
medical services to patients who are unable to pay
$20,285,930
COMMUNITY BENEFIT BY CATEGORY
*July 2013 – June 2014
n COMMUNITY BENEFIT OPERATIONS
Costs associated with assigned staff, community
health needs and assessments
$17,663
n COMMUNITY BUILDING ACTIVITIES
Cost of programs that address the root causes of
health problems, including in-kind donations and
expenses for the development of community-building
programs and partnerships
Moffitt Cancer Center’s Community Benefit initiative
supports patients, families and clinicians through
advancing cancer prevention, early detection, clinical
care and research, especially for those at-risk populations
disproportionately impacted by cancer.
The Community Health Needs Assessment results showed
variations in the community’s ability to translate knowledge
into healthy behaviors and the community’s perceptions
of cancer that create barriers to seeking proactive care.
Moffitt provides cancer prevention and early detection
education and outreach to at-risk and underserved
communities to increase cancer knowledge, awareness
and advocacy.
$62,443
n HEALTH PROFESSIONS EDUCATION
Cost associated with clinical education and training
for physicians and medical students not including
government funding
EDUCATION AND OUTREACH
Medicaid
Shortfalls
Traditional
Charity Care
•
6,687 community members attended workshops
and received information on cancer prevention, early
detection and healthy lifestyles through the Moffitt
Program for Outreach Wellness Education and
Resources (M-POWER)
•
849 individuals were reached through the
education, outreach, and advocacy events of the Lung
and Thoracic Tumor Education (LATTE) Program
Health Professions
Education
Community Health
Improvement
Services
$8,872,934
n COMMUNITY HEALTH
IMPROVEMENT SERVICES
Cost of activities carried out to improve community
health beyond patient care
Research
Community
Building Activities
Community Benefit
Operations
$643,048
n MEDICAID SHORTFALLS
•
and informed decision-making education at the 2015
Men’s Health Forum
•
The Medicaid program pays Moffitt less than it
costs the organization to provide care to its
Medicaid patients.
TOTAL COMMUNITY BENEFIT DOLLARS:
$71,792,466
$11,012,819
n RESEARCH
Clinical and community health research, as well
as general health care delivery studies shared with
the public and funded by the government or a
tax-exempt entity
161 men received vital prostate cancer screening
1,935 children were educated about the
importance and benefits of healthy behaviors
through the Moffitt Healthy KIDZ Program
ACCESS
Findings from the Community Health Needs Assessment
indicate that barriers beyond having health insurance exist
to accessing and utilizing cancer treatment programs and
services.
Moffitt aims to enhance access to screening, prevention,
treatment and recovery services for all community
members to help alleviate barriers to care and support
patient- and family-centered care.
•
971 vouchers were disseminated to alleviate
transportation barriers for qualifying patients
•
1,099 individuals were screened for skin cancer
within the community through Moffitt’s Mole Patrol®
•
109 men received access to prostate cancer
screenings through a voucher program at the 2015
Men’s Health Forum
$30,897,629
•
592 women received access to mammography
screenings through a voucher program
8
*2015 Community Benefit figures can be provided upon request after January 2016.
9
HIGHLIGHTS 2015
n MOFFITT RECEIVES $3.6 MILLION GRANT
TO STUDY E-CIGARETTES
n BUSINESS OF BIOTECH FEATURES
SAM DONALDSON AND GENZYME PIONEER
A $3.6 million grant from the National Institutes of Health
will enable Moffitt researchers to study the use of electronic
cigarettes, or e-cigarettes, and their value for quitting
smoking, over the next five years.
Former ABC news
correspondent and
member of Moffitt’s
Board of Advisors
Sam Donaldson
(right) interviews
Henri Termeer,
keynote speaker
at Moffitt’s 9th
Annual Business
of Biotech Conference, held April 17, 2015. Termeer built
Genzyme, a pioneer in developing treatments for rare
diseases and at one point the third largest biotechnology
company worldwide.
n MOFFITT TREATS FIRST PATIENT
WITH KTE-C19 THERAPY
Moffitt treated the first patient nationally in a clinical trial
of KTE-C19 for aggressive non-Hodgkin lymphoma. The Kite
Pharma trial studied KTE-C19, an investigational therapy in
which a patient’s T cells are genetically modified to target a
protein expressed on the cell surface of B-cell lymphomas
and leukemias.
n GRANT FUNDING IS INCREASED
Grant funding at Moffitt increased from $46,943,049 in
fiscal year 2014 to $51,869,126 in fiscal year 2015, of which
$40,465,957 were funds from peer-reviewed grants.
n KAY YOW CANCER FUND AWARDS
$1.25 MILLION RESEARCH GRANT
The Kay Yow Cancer Fund®, in partnership and collaboration
with The V Foundation for Cancer Research, presented a
$1.25 million ovarian cancer research grant to Moffitt. The
Kay Yow Cancer Fund previously announced a $250,000
grant to Moffitt in conjunction with the 2015 NCAA Women’s
Final Four. The additional $1 million grant is awarded based
on the merits of the project, led by Moffitt medical oncologist
Martine Extermann, M.D., Ph.D.
n MOFFITT RESEARCH IS FEATURED
ON COVER OF SCIENCE SIGNALING
In a research paper featured
on the cover of the Jan.
13, 2015, issue of Science
Signaling, Eric Haura, M.D.,
and colleagues reported a
new approach to measure
how signaling-associated
proteins may have the
potential to add to current
biomarker tests for drug
sensitivity. Dr. Haura, who
leads the Chemical Biology &
Molecular Medicine Program
and directs the Lung Cancer
Center of Excellence at Moffitt, says the research team
hopes the knowledge will translate into new personalized
medicine strategies for patients.
10
HIGHLIGHTS 2015
n ORIEN “BIG DATA” COLLABORATIVE
ADDS TWO NEW MEMBERS
The Oncology Research Information Exchange Network
(ORIEN) announced the addition of Rutgers Cancer Institute
of New Jersey and the University of Southern California
Norris Comprehensive Cancer Center to the cancer research
collaboration, bringing the number of network members to 10.
n FOUNDATION SUPPORT
EXCEEDS 13.6 MILLION
Through fiscal year 2015 the Moffitt Foundation provided
more than $13.6 million in distributions for research, patient
care, education and equipment at Moffitt. The distributions
included support of programs that commit to cancer
education and early detection awareness.
n MAGNOLIA BALL RAISES
MORE THAN $3 MILLION
The 2015 Magnolia Ball raised more than $3 million – thanks
to the commitment and generosity of more than 800 guests
and Event Chairs Sandi and Chris Sullivan, Honorary Chairs
Don and Mary Anne Shula, and Presenting Sponsor Skanska
USA Building Inc. A highlight of this year’s ball was a match
gift challenge made possible by the $500,000 donation by
Tampa philanthropists and Moffitt supporters Frank and
Carol Morsani. The match alone raised $2.7 million to help
provide advanced treatment options and support services
to patients and their families. Also that evening Moffitt
President and CEO Dr. Alan List announced a pledged gift
of $500,000 from the Vinik Foundation.
n $1.6 MILLION GRANT SUPPORTS
LUNG CANCER SCREENING RESEARCH
Moffitt Thoracic Oncology Department Chair Scott Antonia,
M.D., Ph.D., received an infrastructure grant from Florida’s
James and Esther King Biomedical Research Program.
The three-year $1.6 million grant titled “Expansion of
Enduring Infrastructure to Support Lung Cancer Screening
Research” will help fund Moffitt’s comprehensive lung
screening program.
n MOFFITT, M2GEN TO COORDINATE
BIOREPOSITORY SERVICES FOR MDS
Moffitt and M2Gen® were awarded a contract from the
National Institutes of Health’s National Heart, Lung, and
Blood Institute to serve as the Central Laboratory and
Biorepository for The National Myelodysplastic Syndromes
Natural History Study. In collaboration with the National
Cancer Institute clinical study programs, more than 150 sites
around the nation are expected to participate in this study.
The $7.3 million project at Moffitt/M2Gen represents the
first federally funded contract for biorepository services and
demonstrates the high standards set forth by the institution.
n HEALTHY LIVING, CANCER PREVENTION
PARTNERSHIP IS ANNOUNCED
A new partnership
that encourages
Florida-based
solutions to prevent
cancer and empowers
Floridians to live
stronger, healthier
lives was announced
between Moffitt and
Florida Commissioner
of Agriculture Adam
H. Putnam. Created by the Florida Department of Agriculture
and Consumer Services, “Living Healthy in Florida” provides
simple tools to promote healthy living and cancer prevention.
The partnership was announced on the 10th annual Moffitt
Day, held at the State Capitol on Feb. 17, 2015.
“Our partnership with Moffitt will take the “Living Healthy
in Florida’ initiative to a new level, highlighting the center’s
expertise on cancer prevention and treatment to further
educate Floridians about the importance of making healthy
choices,” Putman said. “Together, with partners like Moffitt,
we can create healthier communities and reduce long-term
healthcare costs associated with chronic disease.”
n MILES FOR MOFFITT
CELEBRATES 10TH ANNIVERSARY
The 2015 PNC Bank Miles for Moffitt® celebrated the event’s
10th anniversary. Thanks to generous supporters, runners
and donors, the event raised over $650,000, bringing the
total to $3 million since 2006.
n OTMC REPORTS RECORD YEAR
WITH $22 MILLION IN GLOBAL FUNDING
The Office of Technology Management and
Commercialization (OTMC) at Moffitt finished another
successful year, having brought more than $22 million
in global funding to Moffitt. The majority of this funding
emerged from licensing arrangements and industry
alliances. During fiscal year 2015, OTMC efforts were
responsible for four trademarks, eight startups, 18 licenses
and 13 U.S. patents issued – with 39 original U.S. patent
applications and 115 worldwide patent applications.
n NEW MCKINLEY OUTPATIENT CENTER
WILL PROVIDE EXPANDED SERVICES
The Moffitt McKinley
Outpatient Center, a sixstory, 207,000-squarefoot facility is scheduled
to open November
2015. The facility meets
a critical need for
expanded outpatient
services, including ambulatory surgery and more.
n INTERNATIONAL TRIAL LEADS
TO HPV VACCINE
In December 2014, the U.S. Food and Drug Administration
approved Gardasil 9, a vaccine that protects against nine
human papillomavirus (HPV) types, following an international
phase II/III clinical trial involving Moffitt faculty. Anna R.
Giuliano, Ph.D., led the Moffitt team. The vaccine trial results
were published Feb. 19, 2015, in The New England Journal
of Medicine, and the trial was funded by Merck & Co., Inc.
n DON SHULA FOUNDATION JOINS FIGHT
TO END BREAST CANCER
The Don Shula Foundation was
established more than 20 years
ago, and through the foundation,
the Shulas have supported breast
cancer research at Moffitt for
nearly a decade. On July 15, 2014,
Don Shula and his wife, Mary
Anne, announced that they were
donating the Shula Foundation
funds of $1.5 million to Moffitt
and establishing The Don Shula
Breast Cancer Research Fund
(The Shula Fund).
11
NEW LEADERS 2015
ACCOLADES & RECOGNITIONS 2015
MOFFITT TOPS HOSPITALS
IN FLORIDA FOR CANCER CARE
MOFFITT ACHIEVES
NURSING MAGNET® RECOGNITION
Moffitt is the top-ranked cancer hospital in Florida based
on the U.S. News & World Report Best
Hospitals for Cancer Care rankings
released July 21, 2015. Moffitt is No.
18 overall in cancer. Moffitt, the only
National Cancer Institute-designated
Comprehensive Cancer Center based
in Florida, has been recognized by
U.S. News since 1999.
Moffitt earned the prestigious Magnet® designation in
recognition of its nursing excellence. Magnet recognition
is granted by the American Nurses Credentialing Center
(ANCC), the credentialing body of the American Nurses
Association, to honor outstanding
health care organizations
for nursing professionalism,
teamwork, quality patient care
and innovations in nursing
practices. Today, only 7 percent
of national and international health
care organizations are recognized by the ANCC Magnet
Recognition Program®.
MOFFITT IS RECOGNIZED
FOR GREAT ONCOLOGY PROGRAMS
Becker’s Hospital Review has named Moffitt as one of
the 2015 “100 Hospitals and Health Systems with Great
Oncology Programs.” Hospitals chosen are leading the
way in terms of quality patient care, cancer outcomes
and research. All hospitals that made the list, including
Moffitt, have received recognition from several ranking
agencies, including U.S. News & World Report, the
National Cancer Institute, the American College of
Surgeons Commission on Cancer, CareChex and the
BlueCross BlueShield Association.
MOFFITT RECEIVES CANCER CENTER
OF EXCELLENCE AWARD
Moffitt received the Cancer Center of Excellence Award
from State Surgeon General and Secretary of Health
Dr. John Armstrong. The
Cancer Center of Excellence
program promotes excellence
in cancer care, encourages
the recruitment of the best
cancer care professionals and
recognizes state institutions
as a preferred destination for
patient-centered cancer care.
“The first ever Cancer Center
of Excellence Awards in Florida
reflect the state-of-the-art, patient-centered cancer care
available right here in our great state,” said State Surgeon
General and Secretary of Health Dr. John Armstrong.
MOFFITT IS NAMED
BEST PLACE TO WORK
Moffitt has been named a Best Place to Work in numerous
publications, including the Tampa Bay Times and Working
Mother Magazine.
12
MOFFITT AWARDED FOR SUPPORTING
SUPPLY CHAIN DIVERSITY
Moffitt received the Diversity Award by Premier Inc. for
supporting supply chain diversity as part of its social
responsibility initiatives. The award honors health systems
that have established active programs to evaluate and
support minority-, women- and veteran-owned enterprises,
as well as small businesses, available through the Premier
contract portfolio.
AACR NAMES DR. MULÉ
MASTER OF IMMUNOLOGY
James J. Mulé, Ph.D., associate center director for
Translational Science at Moffitt, has been named a Master
of Immunology by the American
Association for Cancer Research
online and print publication
Cancer Immunology Research .
The distinction recognizes his life’s
contributions to cancer research.
The results of his life’s work have
helped shape the future of cancer
therapy through the development of personalized
immunotherapies that use a patient’s own immune system
to fight his or her disease.
DR. LIST RECEIVES
LEADERSHIP IN SCIENCE AWARD
Alan F. List, M.D., Moffitt President and CEO, received the
2014 Leadership in Science Award from the Aplastic Anemia
& MDS International Foundation. Dr. List was recognized
for his contributions to the fields of bone marrow failure
disease treatment and/or research.
Welcome, New Leaders
We are pleased to announce several key appointments at Moffitt during 2015.
CHRISTINE H. CHUNG, M.D.
has been appointed chair of the
Department of Head and Neck, and
Endocrine Oncology, and senior
member. Dr. Chung joins Moffitt from
Johns Hopkins University, where she
directed the Head and Neck Cancer
Therapeutics Program in the Department of Oncology
and Otolaryngology.
LOUIS B. HARRISON, M.D.
has been appointed chair of the
Department of Radiation Oncology
and senior member. Dr. Harrison
is an internationally recognized
and extensively published expert in
the areas of head and neck cancer,
sarcomas and intraoperative brachytherapy.
ROBERT J. KEENAN, M.D
joins Moffitt as vice president of
Quality and chief medical officer,
and senior member, Department of
Thoracic Oncology. Dr. Keenan provides
leadership and medical expertise in
the areas of patient safety, utilization
review, quality improvement, clinical informatics, risk
management, infection control, credentialing, by-laws, safety
and clinical outcomes.
MARIANA BUGALLO-MUROS
has been named vice president, chief
human resources officer, following
a national search. Bugallo-Muros
succeeded Joanne Olson, who retired
in March 2015.
JENNIFER GREENMAN
was appointed vice president and chief
information officer. She will provide
leadership and strategic direction for
technology initiatives that support
Moffitt’s mission.
NAVEEN KUMAR
has been named vice president of
Strategy and Business Development at
M2Gen®, Moffitt Cancer Center’s wholly
owned, for-profit, informatics solution
subsidiary advancing personalized
medicine. Kumar will oversee the
development and execution of M2Gen’s commercial activities
and corporate growth strategy.
T. COLE PETERSON, J.D., M.H.A.
was named vice president, Deputy
General Counsel. Peterson joined
Moffitt in 2013 as associate general
counsel.
CINDY TERRANO, CPA
is Moffitt’s new vice president of Payer
Strategies, a position that is critical
to the success of the cancer center’s
strategic plan in partnering with payers
and other organizations.
JOANNA WEISS, CPA
is Moffitt’s new vice president of
Revenue Cycle Management. Weiss
has been with the cancer center
since 2006, and will be responsible
for Patient Access, Health Information
Management and Patient Financial
Services for Moffitt and the Moffitt Medical Group.
13
LEADERSHIP 2015
Board of Directors
H. LEE MOFFITT CANCER CENTER &
RESEARCH INSTITUTE, INC.
Robert Rothman, Chair
Timothy J. Adams, Vice Chair
Carlos Alfonso
Jorge Arrizurieta
Angela Biever
The Honorable Carl Carpenter, Jr.
Theodore J. Couch, Sr., Chair Emeritus
Edward DeBartolo
Edward C. Droste
Celia D. Ferman
Judy L. Genshaft, Ph.D.
The Honorable John A. Grant
The Honorable James T. Hargrett
Benjamin H. Hill, III, Esq.
Beth A. Houghton
Senator Connie Mack, Chair Emeritus
The Honorable H. Lee Moffitt
John Ramil
Francisco J. Sanchez
Liz Smith
John Tomlin
LEADERSHIP 2015
Frank Capitano
Hugo Fernandez, M.D.
G. Douglas Letson, M.D.
Allan S. Martin
The Honorable H. Lee Moffitt
Michael J. O’Malley
Robert J. Perez, D.D.S., F.A.G.D.
The Honorable Mark A. Pizzo
Julio Pow-Sang, M.D.
The Honorable Donald C. Sullivan, M.D.
Lorna Taylor
Mark Watson
PHIL JONES
Former Correspondent, CBS News
LESA FRANCE KENNEDY
CEO and Vice Chairperson of the Board of Directors,
International Speedway Corporation (ISC);
Vice Chairperson of NASCAR
Theodore J. Couch, Sr., Chair
Senator Connie Mack, Vice Chair
William S. Dalton, Ph.D., M.D.
Kenneth Ford, Ph.D.
John A. Kolosky, C.P.A., M.B.A.
Kenneth I. Moch
The Honorable H. Lee Moffitt
Linda Powers
Robert Rothman
Daniel M. Sullivan, M.D.
Chairman, President and Chief Executive Officer, National
Bank Holdings Corporation (NBH)
RHEA LAW
GOVERNOR BOB MARTINEZ
Senior Policy Advisor, Holland & Knight LLP;
Former Governor of Florida;
Former Mayor of Tampa
MARTIN J. MURPHY JR., PH.D.
Chairman and Chief Executive Officer,
Alpha Med Consulting, Inc.
MARTY NEALON
Managing Partner, Golden Seeds
OLIVIA NEWTON-JOHN
Singer, Actress, and Health Advocate
H. LEE MOFFITT CANCER CENTER &
RESEARCH INSTITUTE HOSPITAL, INC.
Beth A. Houghton, Chair
The Honorable Mark A. Pizzo, Vice Chair
W. Michael Alberts, M.D., M.B.A., F.A.C.P, F.C.C.P.
Michael O. Bice
Joseph Caballero
Roland Daniels
Valerie Goddard
G. Douglas Letson, M.D.
Jo Manion, Ph.D.
The Honorable H. Lee Moffitt
Orlando Nieves
The Honorable Mark A. Pizzo
Nick Porter
Mary Anne Reilly
BOB GRIESE
Chair, Moffitt Board of Advisors
Miami Dolphins Radio Analyst
Member, College and Pro Football Halls of Fame
CLIFFORD L. ALEXANDER JR.
President, Alexander & Associates, Inc.;
Former Secretary of the Army
GARY BETTMAN
Commissioner, National Hockey League
Center Director
THOMAS A. SELLERS, PH.D., M.P.H.
Executive Vice President
ARNOLD PALMER
Professional Golfer and Businessman
STEVE RAYMUND
Chairman, Tech Data Corporation
COKIE ROBERTS
ABC News Political Commentator;
Contributing Senior News Analyst, National Public Radio
MEL SEMBLER
Chairman Emeritus,
The Sembler Company;
United States Ambassador, Retired
ASSOCIATE CENTER DIRECTORS
JOHN CLEVELAND, PH.D.
Basic Science
JULIE Y. DJEU, PH.D.
Education and Training
PAUL B. JACOBSEN, PH.D.
Population Science
SUSAN L. STERN, C.F.R.E.
Foundation
CINDY TERRANO
Payer Strategies
JOANNA WEISS
Revenue Cycle Management
JAMIE WILSON
Government Relations
RESEARCH DEPARTMENTS
MOLECULAR ONCOLOGY
Jin Q. Cheng, M.D., Ph.D.
Department Chair [Interim]
JAMES J. MULÉ, PH.D.
Translational Science
DRUG DISCOVERY
Saïd Sebti, Ph.D.
Department Chair
BRIAN C. SPRINGER, M.H.A.
Research Administration
Vice President
IMMUNOLOGY
Kenneth L. Wright, Ph.D.
Department Chair (Interim)
DANIEL M. SULLIVAN, M.D.
Clinical Science
TUMOR BIOLOGY
Srikumar Chellappan, Ph.D.
Department Chair
EXECUTIVE VICE PRESIDENTS
INTEGRATED MATHEMATICAL ONCOLOGY
Alexander Anderson, Ph.D.
Department Chair
L. DAVID DE LA PARTE, ESQ.
General Counsel
JOHN A. KOLOSKY, C.P.A., M.B.A.
Chief Operating Officer;
President, Moffitt Hospital
CANCER IMAGING AND METABOLISM
Robert J. Gillies, Ph.D.
Department Chair
CANCER EPIDEMIOLOGY
Peter Kanetsky, Ph.D., M.P.H.
Department Chair
DONALD A. ADAM COMPREHENSIVE MELANOMA
RESEARCH CENTER OF EXCELLENCE
Jeffrey S. Weber, M.D., Ph.D., Director
CENTER FOR INFECTION RESEARCH IN CANCER
Anna R. Giuliano, Ph.D., Director
CANCER IMAGING AND TECHNOLOGY CENTER
OF EXCELLENCE
Robert J. Gillies, Ph.D., Director
Robert Gatenby, M.D., Co-Director
Antony Magliocco, M.D., Co-Director
DIVISION OF CLINICAL SCIENCES
ANATOMIC PATHOLOGY
Anthony M. Magliocco, M.D., Department Chair
ANESTHESIOLOGY
David Thrush, M.D., Department Chair
BLOOD & MARROW TRANSPLANT
Claudio Anasetti, M.D., Department Chair
BREAST ONCOLOGY
Bryan McIver, M.D., Ph.D., Department Chair
(Interim)
CUTANEOUS ONCOLOGY
Vernon Sondak, M.D., Department Chair
DIAGNOSTIC IMAGING AND INTERVENTIONAL
RADIOLOGY
Robert Gatenby, M.D., Department Chair
GASTROINTESTINAL ONCOLOGY
Mokenge Malafa, M.D., Department Chair
GENITOURINARY ONCOLOGY
Julio Pow-Sang, M.D., Department Chair
DON SHULA
G. DOUGLAS LETSON, M.D.
Physician-in-Chief, President, MMG
Former Chancellor, Appalachian State University;
Former President, University of South Florida
NFL’s Winningest Coach;
Member of Pro Football Hall of Fame
Chairman, Shula Enterprises, Inc.
YVETTE TREMONTI, C.P.A.
Chief Financial Officer
H. LEE MOFFITT CANCER CENTER &
RESEARCH INSTITUTE FOUNDATION, INC.
KIM CASIANO
STUART STERNBERG
HEALTH OUTCOMES AND BEHAVIOR
Thomas H. Brandon, Ph.D.
Department Chair
Principal Owner, Tampa Bay Rays Ltd.
SENIOR VICE PRESIDENTS
Edward C. Droste, Chair
Peter T. Kirkwood, Esq., Vice Chair
Kiersten L. Allen
Paul Anderson
Carmen Barkett
William Brand
Joseph Caballero
The Honorable Monterey Campbell
Ronald J. Campbell
Peter Campo, Ph.D.
Eileen Sena Curd
S. Katherine Frazier, Esq.
Richard Gonzmart
Shay Griese
Cindy Gruden
Timm Harmon
Benjamin H. Hill, III, Esq.
Sean Hyer
Frederick Lynch
The Honorable H. Lee Moffitt
Jim U. Morrison
Carol Morsani
Jim Overton
Barbara Ryals
Lansing Scriven, Esq.
Patrick Sobers
John Spangler
Don W. Wallace
Julie Wooley
DAVID S. CHERNOW
SUSAN STORY
MARK HULSE, R.N.
Chief Administrative Officer
BIOSTATISTICS AND BIOINFORMATICS
Jae K. Lee, Ph.D.
Department Chair
HEMATOPATHOLOGY & LABORATORY MEDICINE
Lynn C. Moscinski, M.D., Department Chair
RESEARCH PROGRAMS
INTERNAL MEDICINE
Bjorn Holmström, M.D., Department Chair (Interim)
MOFFITT MEDICAL GROUP
Timothy J. Adams, Chair
Joedrecka Brown Speights, M.D.
14
Board of Advisors
President & Chief Executive Officer
ALAN F. LIST, M.D.
G. TIMOTHY LANEY
Chair, Florida Offices, Buchanan Ingersoll & Rooney P.A.
M2GEN®
Internal Leadership
FRANCIS T. BORKOWSKI, PH.D.
President, Kimberly Casiano & Associates, Inc.
President and Chief Executive Officer,
Select Medical Corporation
ROBIN COOK, M.D.
Physician and Author
SAM DONALDSON
Former ABC News Correspondent;
Chair Emeritus, Board of Advisors
EDWARD C. DROSTE
Chairman, Provident Management Corporation
NEWT GINGRICH
Former Speaker of the U.S. House of Representatives
BRYAN GLAZER
Co-Chairman, Tampa Bay Buccaneers
Chief Executive Officer
America Water
CHRIS T. SULLIVAN
Partner
MVP Holdings, Inc.
NICK VALVANO
President Emeritus,
The V Foundation for Cancer Research
ANN MORGAN VICKERY
Of Counsel
Hogan Lovells
GOVERNOR BOB WISE
BRIAN GRIESE
College Football Analyst, ABC/ESPN;
Founder & President, Judith Ann Griese Foundation
MARTI HUIZENGA
Community Volunteer
ROBERT INGRAM
General Partner,
Hatteras Venture Partners
MIKE JACKSON
Chairman, CEO and President,
AutoNation, Inc.
VICE PRESIDENTS
MARIANA BUGALLO-MUROS
Chief Human Resources Officer
JANE FUSILERO, R.N., M.S.N., MBA, NEA-BC
Patient Care Services, Chief Nursing Officer
President, Alliance for Excellent Education;
Former Governor of West Virginia
DON FUTRELL
Facilities and Support Services
EMERITUS
B. LEE GREEN, PH.D.
Diversity & Community Relations
SENATOR BOB GRAHAM
Former U.S. Senator;
Former Governor of Florida
BRAULIO VICENTE, JR.
Hospital & Physician Group Operations
SENATOR BOB DOLE
Special Counsel, Alston & Bird;
Former U.S. Senator
SIDNEY KIMMEL
Founder & Chairman, Jones Apparel Group;
Chairman, Sidney Kimmel Foundation
TOM O’BRIEN
Retired President & Chief Executive Officer,
AAA Auto Club South
JENNIFER GREENMAN
Chief Information Officer
DIANE HAMMON
Strategic Development
ROBERT J. KEENAN, M.D.
Quality
Chief Medical Officer
T. COLE PETERSON, ESQ.
Deputy General Counsel
GYNECOLOGIC ONCOLOGY
Sachin Apte, M.D., Department Chair
HEAD AND NECK; ENDOCRINE ONCOLOGY
Christine H. Chung, M.D., Department Chair
CANCER BIOLOGY AND EVOLUTION
Robert Gatenby, M.D.
Program Leader
INTERNAL & HOSPITAL MEDICINE PROGRAM
Bjorn Holmström, M.D., Program Leader
(Interim)
CANCER EPIDEMIOLOGY
Peter Kanetsky, Ph.D., M.P.H.
Program Leader
SENIOR ADULT ONCOLOGY PROGRAM
Lodovico Balducci, M.D., Program Leader
CHEMICAL BIOLOGY AND MOLECULAR MEDICINE
Eric B. Haura, M.D.
Saïd Sebti, Ph.D.
Program Leaders
HEALTH OUTCOMES AND BEHAVIOR
Thomas H. Brandon, Ph.D.
Program Leader
IMMUNOLOGY
Claudio Anasetti, M.D.
Kenneth Wright, Ph.D. (Interim)
Program Leaders
MALIGNANT HEMATOLOGY
Jeffrey E. Lancet, M.D., Department Chair (Interim)
NEURO-ONCOLOGY
Peter Forsyth, M.D., Department Chair
RADIATION ONCOLOGY
Louis Harrison, M.D., Department Chair
SARCOMA
Ricardo Gonzalez, M.D., Department Chair
ADOLESCENT AND YOUNG ADULT PROGRAM
Damon Reed, M.D., Program Leader
CENTERS OF EXCELLENCE
SUPPORTIVE CARE MEDICINE
Diane Portman, M.D., Department Chair
LUNG CANCER RESEARCH CENTER
OF EXCELLENCE
Eric B. Haura, M.D., Director
THORACIC ONCOLOGY
Scott Antonia, M.D., Ph.D., Department Chair
DANA ROLLISON, PH.D.
Chief Health Information Officer
15
MOFFITT CANCER CENTER LOCATIONS
MOFFITT CANCER CENTER 12902 MAGNOLIA DRIVE
Moffitt offers all levels of care for people with cancer and related diseases.
MOFFITT CANCER CENTER AT INTERNATIONAL PLAZA 4101 JIM WALTER BOULEVARD
Moffitt’s satellite facility near International Plaza in Tampa provides expanded and easily
accessible patient services.
MOFFITT MCKINLEY OUTPATIENT CENTER 10920 North McKinley Drive
Opening fall 2015, the McKinley Center fulfills a critical need to meet the demand for expanded
outpatient services. The facility will house an outpatient surgery center, a cutaneous clinic,
a breast clinic, breast imaging services, genetic counseling and more. Additionally, Moffitt
Screening and Prevention is relocating to McKinley.
1-888-MOFFITT (1-888-663-3488) | MOFFITT.ORG
www.facebook.com/MoffittCancerCenter |
twitter.com/MoffittNews
Vice President, Moffitt Diversity and Community Relations: B. Lee Green, Ph.D.
Director, Public Relations and Strategic Communications: Mark Hendrickson | Managing Editor: Cathy Clark | Design: Delta Blue Studio
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, AN NCI COMPREHENSIVE CANCER CENTER - TAMPA FL
© 2015 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC All rights reserved.
Florida is the official place of business for the Moffitt Cancer Center Foundation. A copy of the official registration and financial information may be obtained from
the Division of Consumer Services by calling 1-800-435-7352 toll-free within the state or online at www.800helpfla.com. Registration does not imply endorsement,
approval or recommendation by the state. Florida Department of Agriculture & Consumer Services registration number CH-4675. No percentage of contributions
is retained by a professional solicitor; Moffitt Cancer Center Foundation receives 100% of all donations. Your gift is tax-deductible to the extent allowed by law.